CLRS: Clarus Therapeutics, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Clarus Therapeutics, Inc.

NASDAQ:CLRS

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
n/a
Loss Chance
58.4%
0.25JITTA SCORE
n/a
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (0)
Recent Business Performance (30)
Financial Strength (0)
Return to Shareholders (10)
Competitive Advantage (0)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Recent Business PerformanceEarning decline 27.80% in the last quarter (yoy)
Key Stats
Jitta Score
Jitta Line
0.25
n/a
3.03
208.13%
n/a
n/a
COMPANY DESCRIPTION
Clarus Therapeutics, Inc. operates as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. Clarus Therapeutics, Inc. was founded in 2003 and is based in Northbrook, Illinois.
www.clarustherapeutics.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.